Global Molecular Diagnostics in Infectious Disease Testing Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1383

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Technological advancement in diagnostic procedures for infectious diseases, the increasing prevalence of infectious diseases, a growing elderly population, and the growth of research activities in molecular diagnostic technologies are some major drivers for the global molecular diagnostics in infectious disease testing market.
In 2018, the global Molecular Diagnostics in Infectious Disease Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Molecular Diagnostics in Infectious Disease Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics in Infectious Disease Testing development in United States, Europe and China.

The key players covered in this study
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics

Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others

Market segment by Application, split into
Hospitals
Clinics
Academic Institutes
Laboratories
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Molecular Diagnostics in Infectious Disease Testing status, future forecast, growth opportunity, key market and key players.
To present the Molecular Diagnostics in Infectious Disease Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Molecular Diagnostics in Infectious Disease Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Polymerase Chain Reaction (PCR)
1.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.4.4 Microarrays
1.4.5 Next-Generation Sequencing (NGS)
1.4.6 Hybridization
1.4.7 Others
1.5 Market by Application
1.5.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic Institutes
1.5.5 Laboratories
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Molecular Diagnostics in Infectious Disease Testing Market Size
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Regions
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2014-2025)
2.2.2 Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Manufacturers
3.1.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.2 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.3 Key Players Molecular Diagnostics in Infectious Disease Testing Product/Solution/Service
3.4 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2014-2019)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2014-2019)

5 United States
5.1 United States Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
5.2 Molecular Diagnostics in Infectious Disease Testing Key Players in United States
5.3 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type
5.4 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application

6 Europe
6.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
6.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Europe
6.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type
6.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application

7 China
7.1 China Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
7.2 Molecular Diagnostics in Infectious Disease Testing Key Players in China
7.3 China Molecular Diagnostics in Infectious Disease Testing Market Size by Type
7.4 China Molecular Diagnostics in Infectious Disease Testing Market Size by Application

8 Japan
8.1 Japan Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
8.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Japan
8.3 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Type
8.4 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
9.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Southeast Asia
9.3 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Type
9.4 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Application

10 India
10.1 India Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
10.2 Molecular Diagnostics in Infectious Disease Testing Key Players in India
10.3 India Molecular Diagnostics in Infectious Disease Testing Market Size by Type
10.4 India Molecular Diagnostics in Infectious Disease Testing Market Size by Application

11 Central & South America
11.1 Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size (2014-2019)
11.2 Molecular Diagnostics in Infectious Disease Testing Key Players in Central & South America
11.3 Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size by Type
11.4 Central & South America Molecular Diagnostics in Infectious Disease Testing Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 BD
12.2.1 BD Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.2.5 BD Recent Development
12.3 BioMerieux
12.3.1 BioMerieux Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.3.5 BioMerieux Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Siemens
12.6.1 Siemens Company Details
12.6.2 Company Description and Business Overview
12.6.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.6.5 Siemens Recent Development
12.7 Veridex
12.7.1 Veridex Company Details
12.7.2 Company Description and Business Overview
12.7.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.7.5 Veridex Recent Development
12.8 Luminex
12.8.1 Luminex Company Details
12.8.2 Company Description and Business Overview
12.8.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.8.5 Luminex Recent Development
12.9 GenMark Diagnostics
12.9.1 GenMark Diagnostics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.9.5 GenMark Diagnostics Recent Development
12.10 Qiagen
12.10.1 Qiagen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Molecular Diagnostics in Infectious Disease Testing Introduction
12.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2014-2019)
12.10.5 Qiagen Recent Development
12.11 Genomix Biotech
12.12 BioTheranostics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details